Literature DB >> 4341587

[Influence of L-DOPA on night sleep in parkinsonian patients].

K Kendel, U Beck, C Wita, E Hohneck, H Zimmermann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4341587     DOI： 10.1007/bf00342499

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr (1970)


× No keyword cloud information.
  19 in total

1.  [Polygraphic study of nocturnal sleep in Parkinsonian syndromes. Effects of treatment levo-dopa].

Authors:  A Muratorio; L Murri; G Cerone
Journal:  Riv Neurobiol       Date:  1970 Oct-Dec

2.  [Sleep in parkinsonism].

Authors:  D Traczynska-Kubin; E Atzef; O Petre-Quadens
Journal:  Acta Neurol Psychiatr Belg       Date:  1969-09

3.  Effect of L-dopa on the sleep of man.

Authors:  R J Wyatt; T N Chase; J Scott; F Snyder; K Engleman
Journal:  Nature       Date:  1970-12-05       Impact factor: 49.962

4.  Laboratory note. Effects of methyldopa on sleep patterns in man.

Authors:  F Baekeland; L Lundwall
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1971-09

5.  [Correlation between Parkinsonism symptoms and a disorder in the amino acid metabolism in CNS].

Authors:  E Gründig; F Gerstenbrand
Journal:  Wien Klin Wochenschr       Date:  1970-11-06       Impact factor: 1.704

6.  [Comparative analysis of the effects of Levodopa on sleep in patients with athetosis and parkinsonism treated and not treated with thalamolysis].

Authors:  F M Puca; R Di Perri
Journal:  Riv Neurol       Date:  1970 Sep-Oct

7.  Levodopa's awakening effect on patients with Parkinsonism.

Authors:  G G Marsh; C M Markham; R Ansel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-06       Impact factor: 10.154

8.  Kantamaneni BD, Curzon G:Comparison of benefit from L-dopa in Parkinsonism with increase of amine metabolites in the CSF.

Authors:  R B Godwin-Austen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-06       Impact factor: 10.154

9.  [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

Authors:  H EHRINGER; O HORNYKIEWICZ
Journal:  Klin Wochenschr       Date:  1960-12-15

Review 10.  L-dopa therapy in Parkinson's disease: a critical review of nine years' experience.

Authors:  A Barbeau
Journal:  Can Med Assoc J       Date:  1969-12-27       Impact factor: 8.262
View more
  7 in total

1.  Changes in nocturnal sleep in Huntington's and Parkinson's disease.

Authors:  W Emser; M Brenner; T Stober; K Schimrigk
Journal:  J Neurol       Date:  1988-01       Impact factor: 4.849

2.  [Sleep in patients with Parkinson's disease and its influence by L-DOPA (author's transl)].

Authors:  E Schneider; H Maxion; B Ziegler; P Jacobi
Journal:  J Neurol       Date:  1974-06-27       Impact factor: 4.849

3.  Reduced rapid eye movement sleep latency in patients with Parkinson's disease.

Authors:  V S Kostić; V Susić; N Covicković-Sternić; Z Marinković; S Janković
Journal:  J Neurol       Date:  1989-10       Impact factor: 4.849

4.  Respiration and sleep in Parkinson's disease.

Authors:  M C Apps; P C Sheaff; D A Ingram; C Kennard; D W Empey
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

5.  Three-year observation of mesulergine (CU 32-085) in advanced and newly treated parkinsonism.

Authors:  E Schneider; H Baas; P A Fischer; G Japp
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

6.  [Sleep EEG alterations in patients suffering from circulatory disturbances. Relation to neurological and psychopathological changes (author's transl)].

Authors:  E Schneider; B Ziegler; P Jacobi; H Maxion
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1977-02-23

Review 7.  A Review of Sleep and Its Disorders in Patients with Parkinson's Disease in Relation to Various Brain Structures.

Authors:  Isobel T French; Kalai A Muthusamy
Journal:  Front Aging Neurosci       Date:  2016-05-23       Impact factor: 5.750
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.